Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties
Source abstract
Abstract
Defining the interplay between the genetic events and microenvironmental contexts necessary to initiate tumorigenesis in normal cells is a central endeavour in cancer biology. We found that receptor tyrosine kinase (RTK)-Ras oncogenes reprogram normal, freshly explanted primary mouse and human cells into tumour precursors, in a process requiring increased force transmission between oncogene-expressing cells and their surrounding extracellular matrix. Microenvironments approximating the normal softness of healthy tissues, or blunting cellular mechanotransduction, prevent oncogene-mediated cell reprogramming and tumour emergence. However, RTK-Ras oncogenes empower a disproportional cellular response to the mechanical properties of the cell's environment, such that when cells experience even subtle supra-physiological extracellular-matrix rigidity they are converted into tumour-initiating cells. These regulations rely on YAP/TAZ mechanotransduction, and YAP/TAZ target genes account for a large fraction of the transcriptional responses downstream of oncogenic signalling. This work lays the groundwork for exploiting oncogenic mechanosignalling as a vulnerability at the onset of tumorigenesis, including tumour prevention strategies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Hippo pathway signaling and YAP/TAZ · Cellular Mechanics and Interactions · Microtubule and mitosis dynamics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).10.1126/science.aaa6806 ↗
2. Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).10.1038/s41586-018-0811-x ↗
3. Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).10.1038/s41586-019-1672-7 ↗
4. Panciera, T., Azzolin, L., Cordenonsi, M. & Piccolo, S. Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18, 758–770 (2017).10.1038/nrm.2017.87 ↗
5. Humphrey, J. D., Dufresne, E. R. & Schwartz, M. A. Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell Biol. 15, 802–812 (2014).10.1038/nrm3896 ↗
6. Northey, J. J., Przybyla, L. & Weaver, V. M. Tissue force programs cell fate and tumor aggression. Cancer Discov. 7, 1224–1237 (2017).10.1158/2159-8290.CD-16-0733 ↗
7. Sanchez-Vega, F. et al. Oncogenic signaling pathways in the cancer genome atlas. Cell 173, 321–337 (2018).10.1016/j.cell.2018.03.035 ↗
8. Van Keymeulen, A. et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature 525, 119–123 (2015).10.1038/nature14665 ↗
9. Linnemann, J. R. et al. Quantification of regenerative potential in primary human mammary epithelial cells. Development 142, 3239–3251 (2015).
10. Panciera, T. et al. Induction of expandable tissue-specific stem/progenitor cells through transient expression of YAP/TAZ. Cell Stem Cell 19, 725–737 (2016).10.1016/j.stem.2016.08.009 ↗
11. Acerbi, I. et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr. Biol. 7, 1120–1134 (2015).10.1039/c5ib00040h ↗
12. Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891–906 (2009).10.1016/j.cell.2009.10.027 ↗
13. Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241–254 (2005).10.1016/j.ccr.2005.08.010 ↗
14. Gauthier, N. C., Masters, T. A. & Sheetz, M. P. Mechanical feedback between membrane tension and dynamics. Trends Cell Biol. 22, 527–535 (2012).10.1016/j.tcb.2012.07.005 ↗
15. Brusatin, G., Panciera, T., Gandin, A., Citron, A. & Piccolo, S. Biomaterials and engineered microenvironments to control YAP/TAZ-dependent cell behaviour. Nat. Mater. 17, 1063–1075 (2018).10.1038/s41563-018-0180-8 ↗
16. Parsons, J. T., Horwitz, A. R. & Schwartz, M. A. Cell adhesion: Integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 11, 633–643 (2010).10.1038/nrm2957 ↗
17. Tseng, Y., Kole, T. P. & Wirtz, D. Micromechanical mapping of live cells by multiple-particle-tracking microrheology. Biophys. J. 83, 3162–3176 (2002).10.1016/S0006-3495(02)75319-8 ↗
18. Li, S., Balmain, A. & Counter, C. M. A model for RAS mutation patterns in cancers: Finding the sweet spot. Nat. Rev. Cancer 18, 767–777 (2018).10.1038/s41568-018-0076-6 ↗
19. Guerra, C. et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19, 728–739 (2011).10.1016/j.ccr.2011.05.011 ↗
20. Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737–750 (2012).10.1016/j.ccr.2012.10.025 ↗
21. Burdick, J. A. & Prestwich, G. D. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23, H41–H56 (2011).10.1002/adma.201003963 ↗
22. Zanconato, F. et al. Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. Nat. Med. 24, 1599–1610 (2018).10.1038/s41591-018-0158-8 ↗
23. Gruber, R. et al. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology 151, 526–539 (2016).10.1053/j.gastro.2016.05.006 ↗
24. Scita, G. et al. Signaling from Ras to Rac and beyond: not just a matter of GEFs. EMBO J. 19, 2393–2398 (2000).10.1093/emboj/19.11.2393 ↗
25. Kazanietz, M. G. & Caloca, M. J. The rac GTPase in cancer: from old concepts to new paradigms. Cancer Res. 77, 5445–5451 (2017).10.1158/0008-5472.CAN-17-1456 ↗
26. Heid, I. et al. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 141, 719–730 (2011).10.1053/j.gastro.2011.04.043 ↗
27. Kapoor, A. et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell 158, 185–197 (2014).10.1016/j.cell.2014.06.003 ↗
28. Shao, D. D. et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158, 171–184 (2014).10.1016/j.cell.2014.06.004 ↗
29. Zhang, W. et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci. Signal. 7, ra42 (2014).
30. Vining, K. H. & Mooney, D. J. Mechanical forces direct stem cell behaviour in development and regeneration. Nat. Rev. Mol. Cell Biol. 18, 728–742 (2017).10.1038/nrm.2017.108 ↗
31. Caliari, S. R. & Burdick, J. A. A practical guide to hydrogels for cell culture. Nat. Methods 13, 405–414 (2016).10.1038/nmeth.3839 ↗
32. Sorrentino, G. et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat. Cell Biol. 16, 357–366 (2014).10.1038/ncb2936 ↗
33. Moon, S. H. et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell 176, 564–580 (2019).10.1016/j.cell.2018.11.011 ↗
34. Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl Acad. Sci. USA 76, 5714–5718 (1979).10.1073/pnas.76.11.5714 ↗
35. Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP/TAZ at the roots of cancer. Cancer Cell 29, 783–803 (2016).10.1016/j.ccell.2016.05.005 ↗
36. Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047–1059 (2013).10.1016/j.cell.2013.07.042 ↗
37. Chang, L. et al. The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ. Nature 563, 265–269 (2018).10.1038/s41586-018-0658-1 ↗
38. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179–183 (2011).10.1038/nature10137 ↗
39. Wada, K., Itoga, K., Okano, T., Yonemura, S. & Sasaki, H. Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907–3914 (2011).10.1242/dev.070987 ↗
40. Azzolin, L. et al. Role of TAZ as mediator of Wnt signaling. Cell 151, 1443–1456 (2012).10.1016/j.cell.2012.11.027 ↗
41. Azzolin, L. et al. YAP/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response. Cell 158, 157–170 (2014).10.1016/j.cell.2014.06.013 ↗
42. Morsut, L. et al. Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. Development 137, 2571–2578 (2010).10.1242/dev.053801 ↗
43. Meng, Z. et al. RAP2 mediates mechanoresponses of the Hippo pathway. Nature 560, 655–660 (2018).10.1038/s41586-018-0444-0 ↗
44. Panciera, T. et al. De novo generation of somatic stem cells by YAP/TAZ. J. Vis. Exp. https://doi.org/10.3791/57462 (2018).10.3791/57462 ↗
45. Sanz-Moreno, V. et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 20, 229–245 (2011).10.1016/j.ccr.2011.06.018 ↗
46. Panzetta, V. et al. ECM mechano-sensing regulates cytoskeleton assembly and receptor-mediated endocytosis of nanoparticles. ACS Biomater. Sci. Eng. 3, 1586–1594 (2017).10.1021/acsbiomaterials.7b00018 ↗
47. Panzetta, V. et al. Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues. Acta Biomater. 57, 334–341 (2017).10.1016/j.actbio.2017.05.002 ↗
48. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).10.1093/bioinformatics/bts635 ↗
49. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).10.1093/bioinformatics/btt656 ↗
50. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).10.1093/bioinformatics/btp616 ↗
51. Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).10.1093/nar/gkw377 ↗
52. Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759–772 (2011).10.1016/j.cell.2011.09.048 ↗
53. Rittie, L. Method for picrosirius red-polarization detection of collagen fibers in tissue sections. Methods Mol. Biol. 1627, 395–407 (2017).10.1007/978-1-4939-7113-8_26 ↗